A cytogenetical analysis in patients with secondary hematological disorders

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants.

Leukemia·2017

Cytogenetic Studies in Patients with Acute Myeloid Leukemia Following a Myelodysplastic Syndrome.

Leukemia & lymphoma·2016

Immunophenotype of Abnormal Metaphases Demonstrating Multilineage Involvement in Myelodysplastic Syndromes.

Leukemia & lymphoma·2016

Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV.

Leukemia·2016

Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment.

Leukemia·2015

Predictor factors for renal outcome in renal artery stenosis.

European review for medical and pharmacological sciences·2013

Genetic thrombophilia in cancer-associated thrombosis: the fly plowing with the ox or an old player's new role?

Haematologica·2026

From prognostic discrimination to clinical utility in high-risk myeloma. Comment on: "Risk factors and their contributions to prognosis in multiple myeloma".

Haematologica·2026

Learning from relapse: how MajesTEC-1 immune profiling points the way to next-generation bispecific strategies.

Haematologica·2026

Making remissions last: the promise of maintenance in primary central nervous system lymphoma.

Haematologica·2026

Venetoclax combined with high-dose cytarabine and mitoxantrone for relapsed or refractory acute myeloid leukemia: outcomes and risk stratification.

Haematologica·2026

The many faces (and phenotypes) of BCR::ABL1-driven acute leukemia.

Haematologica·2026

Risk factors for poor prognosis in patients with acute ischaemic stroke: a retrospective study.

Acta cardiologica·2026

A Phase IIa, Double Blind, Randomized, Placebo Controlled, Parallel, Multicentre, Proof-of-Concept Study to Evaluate the Efficacy and Safety of Desidustat Oral Tablet for Treatment of Sickle Cell Disease.

European journal of haematology·2026

Associations of hereditary angioedema attacks with intestinal permeability and inflammatory cytokines.

Frontiers in immunology·2026

Development and Validation of a Nomogram Based on Red Blood Cell and Reticulocyte Parameters for Differentiating Thalassemia Trait From Iron Deficiency Anemia.

Journal of clinical laboratory analysis·2026

Primary Anastomosis Versus Hartmann's Procedure in Acute Care Surgery: Evidence, Indications, and Barriers to Adoption.

The American surgeon·2026

Related Experiment Videos

A cytogenetical analysis in patients with secondary hematological disorders

Related Concept Videos

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants.

Cytogenetic Studies in Patients with Acute Myeloid Leukemia Following a Myelodysplastic Syndrome.

Immunophenotype of Abnormal Metaphases Demonstrating Multilineage Involvement in Myelodysplastic Syndromes.

Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV.

Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment.

Predictor factors for renal outcome in renal artery stenosis.

Genetic thrombophilia in cancer-associated thrombosis: the fly plowing with the ox or an old player's new role?

From prognostic discrimination to clinical utility in high-risk myeloma. Comment on: "Risk factors and their contributions to prognosis in multiple myeloma".

Learning from relapse: how MajesTEC-1 immune profiling points the way to next-generation bispecific strategies.

Making remissions last: the promise of maintenance in primary central nervous system lymphoma.

Venetoclax combined with high-dose cytarabine and mitoxantrone for relapsed or refractory acute myeloid leukemia: outcomes and risk stratification.

The many faces (and phenotypes) of BCR::ABL1-driven acute leukemia.

Risk factors for poor prognosis in patients with acute ischaemic stroke: a retrospective study.

A Phase IIa, Double Blind, Randomized, Placebo Controlled, Parallel, Multicentre, Proof-of-Concept Study to Evaluate the Efficacy and Safety of Desidustat Oral Tablet for Treatment of Sickle Cell Disease.

Associations of hereditary angioedema attacks with intestinal permeability and inflammatory cytokines.

Development and Validation of a Nomogram Based on Red Blood Cell and Reticulocyte Parameters for Differentiating Thalassemia Trait From Iron Deficiency Anemia.

Primary Anastomosis Versus Hartmann's Procedure in Acute Care Surgery: Evidence, Indications, and Barriers to Adoption.

Related Experiment Videos

A cytogenetical analysis in patients with secondary hematological disorders

Related Concept Videos

Related Articles